Literature DB >> 25604323

Chronic type B aortic dissection: indications and strategies for treatment.

F Rohlffs1, N Tsilimparis, H Diener, A Larena-Avellaneda, Y Von Kodolitsch, S Wipper, E S Debus, T Kölbel.   

Abstract

Chronic type B aortic dissection is a distinctive condition that needs individual treatment strategies and different considerations than in therapy of acute or subacute type B aortic dissection. The most common indication for treatment of this complex disease is aneurysmal dilatation of the dissected aortic segment. While open repair of the enlarged dissected aorta remains the best option for good-risk patients and patients with connective tissue disorders in high-volume centers with respective expertise, endovascular management of chronic type B aortic dissection with postdissection aneurysms has significantly gained ground in the past years. But the concept of TEVAR with implantation of a tubular stent-graft into the thoracic aorta to seal the proximal entry tear and reroute the blood flow into the true lumen alone, is not associated with satisfactory results. This is mainly due to the sparse remodeling capacity of the aortic tissue compared to earlier stages of the disease as the aortic wall and the dissection membrane are thickened and more rigid. On the other hand, it is restricted by the most limiting factor for endovascular success in chronic type B aortic dissection: persistent false lumen perfusion. This problem also affects patients with residual dissection after surgical repair of a DeBakey type I aortic dissection or dissection after ascending aortic repair for other pathologies. Hence, it is evident that strategies to achieve endovascular false lumen occlusion are of increasing importance and novel techniques have been introduced to solve the problem of persisting false lumen flow. Thus, the evolution of a large variety of techniques to address the false lumen perfusion issue indicates that complicated chronic type B dissection involves a high diversity in clinical presentation and morphology. A large armamentarium of catheter skills as well as critical individualized treatment strategies are required to address the heterogenous morphological disease pattern for each individual patient. The rapid development in endovascular techniques gives new directions for treatment indications and strategies in chronic aortic dissection and enables new insights into this old disease.

Entities:  

Mesh:

Year:  2015        PMID: 25604323

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  5 in total

1.  Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection.

Authors:  Kristina A Giles; Adam W Beck; Salim Lala; Suzannah Patterson; Martin Back; Javairiah Fatima; Dean J Arnaoutakis; George J Arnaoutakis; Thomas M Beaver; Scott A Berceli; Gilbert R Upchurch; Thomas S Huber; Salvatore T Scali
Journal:  J Vasc Surg       Date:  2018-12-13       Impact factor: 4.268

Review 2.  Type B aortic dissection: new perspectives.

Authors:  Marc A A M Schepens
Journal:  J Vis Surg       Date:  2018-04-23

3.  Favorable Aortic Remodeling Following Serial False Lumen Procedures in a Case of Chronic Type IIIb Dissection.

Authors:  Ahmed Sameh Eleshra; Woon Heo; Kwang-Hun Lee; Shin-Young Lee; Ha Lee; Suk-Won Song
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-08-05

4.  High intimal flap mobility assessed by intravascular ultrasound is associated with better short-term results after TEVAR in chronic aortic dissection.

Authors:  Julia Lortz; Maria Papathanasiou; Christos Rammos; Martin Steinmetz; Alexander Lind; Konstantinos Tsagakis; Thomas Schlosser; Heinz Jakob; Tienush Rassaf; Rolf Alexander Jánosi
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

5.  Baseline 4D Flow-Derived in vivo Hemodynamic Parameters Stratify Descending Aortic Dissection Patients With Enlarging Aortas.

Authors:  Stanley Chu; Ozden Kilinc; Maurice Pradella; Elizabeth Weiss; Justin Baraboo; Anthony Maroun; Kelly Jarvis; Christopher K Mehta; S Chris Malaisrie; Andrew W Hoel; James C Carr; Michael Markl; Bradley D Allen
Journal:  Front Cardiovasc Med       Date:  2022-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.